U.S. flag

An official website of the United States government

NM_000070.3(CAPN3):c.1063C>T (p.Arg355Trp) AND Autosomal recessive limb-girdle muscular dystrophy type 2A

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Sep 24, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000389096.13

Allele description [Variation Report for NM_000070.3(CAPN3):c.1063C>T (p.Arg355Trp)]

NM_000070.3(CAPN3):c.1063C>T (p.Arg355Trp)

Gene:
CAPN3:calpain 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q15.1
Genomic location:
Preferred name:
NM_000070.3(CAPN3):c.1063C>T (p.Arg355Trp)
HGVS:
  • NC_000015.10:g.42394289C>T
  • NG_008660.1:g.51187C>T
  • NM_000070.3:c.1063C>TMANE SELECT
  • NM_024344.2:c.1063C>T
  • NM_173087.2:c.919C>T
  • NP_000061.1:p.Arg355Trp
  • NP_077320.1:p.Arg355Trp
  • NP_775110.1:p.Arg307Trp
  • LRG_849t1:c.1063C>T
  • LRG_849:g.51187C>T
  • LRG_849p1:p.Arg355Trp
  • NC_000015.9:g.42686487C>T
  • NM_000070.2:c.1063C>T
Protein change:
R307W
Links:
dbSNP: rs749099493
NCBI 1000 Genomes Browser:
rs749099493
Molecular consequence:
  • NM_000070.3:c.1063C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024344.2:c.1063C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_173087.2:c.919C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2A (LGMDR1)
Synonyms:
LEYDEN-MOEBIUS MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY, PELVOFEMORAL; Limb-girdle muscular dystrophy, type 2A; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009675; MedGen: C1869123; Orphanet: 267; OMIM: 253600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000793223Counsyl
no assertion criteria provided
Likely pathogenic
(Aug 4, 2017)
unknownclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV000840444Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 25, 2017)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV001200165Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 24, 2024)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

SCV001454334Natera, Inc.
no assertion criteria provided
Pathogenic
(Sep 16, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.

Fanin M, Nascimbeni AC, Tasca E, Angelini C.

Eur J Hum Genet. 2009 May;17(5):598-603. doi: 10.1038/ejhg.2008.193. Epub 2008 Oct 15.

PubMed [citation]
PMID:
18854869
PMCID:
PMC2986267

ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases.

Magri F, Colombo I, Del Bo R, Previtali S, Brusa R, Ciscato P, Scarlato M, Ronchi D, D'Angelo MG, Corti S, Moggio M, Bresolin N, Comi GP.

BMC Neurol. 2015 Sep 24;15:172. doi: 10.1186/s12883-015-0428-8.

PubMed [citation]
PMID:
26404900
PMCID:
PMC4582941
See all PubMed Citations (13)

Details of each submission

From Counsyl, SCV000793223.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota, SCV000840444.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001200165.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 355 of the CAPN3 protein (p.Arg355Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 15689361, 17236769, 19364062, 23821418, 29970176). ClinVar contains an entry for this variant (Variation ID: 281254). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CAPN3 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg355 amino acid residue in CAPN3. Other variant(s) that disrupt this residue have been observed in individuals with CAPN3-related conditions (PMID: 16650086, 28403181), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV001454334.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 13, 2025